The United Kingdom will invest £100 million ($134 million) in a new AI Biosecurity Lab designed to detect emerging biological threats and accelerate the development of vaccines and medical treatments.
The initiative is part of a broader government effort to strengthen national security against risks posed by increasingly capable artificial intelligence systems.
The government described the AI Biosecurity Lab (AIBL) as the world’s first dedicated AI biosecurity organization. OpenAI and Anthropic have committed up to £200 million in AI computing resources, model credits and technical support to the initiative, while Google DeepMind and UK-based Basecamp Research will contribute through research partnerships and access to AI biology capabilities.
Announced on Oct. 24 as part of a broader AI investment package worth more than £600 million ($800 million), the initiative aims to strengthen Britain’s ability to identify biological threats, improve preparedness for disease outbreaks and develop medical countermeasures more rapidly.
The government said the lab would bring together advanced AI capabilities and biological science expertise to help the UK and its international partners better understand, prevent, detect and respond to biological risks, including those emerging from advances in AI itself.
AI Biosecurity Lab to Focus on Threat Detection and Countermeasures
The lab’s initial work will concentrate on two priorities: improving the early detection of emerging biological threats and accelerating the discovery, development and testing of vaccines, treatments and other medical countermeasures.
According to the Cabinet Office, advances in AI are creating new opportunities for scientific discovery while also changing the biological risk landscape. More capable AI systems could support research into diseases and improve medical preparedness, but they could also lower barriers to harmful biological activities.
The new lab is intended to help address both sides of that challenge by translating advances in AI into practical biosecurity capabilities.
It will work with the UK’s national biosecurity institutions, academic researchers, the life sciences industry and international partners. Its research will support efforts to identify emerging threats earlier and improve the speed with which authorities can respond to disease outbreaks and other biological emergencies.
The government has not yet announced the lab’s location, director or launch date. Further details about its scientific advisory committee and organizational arrangements are also expected later.
OpenAI and Anthropic Commit Up to £200M in AI Resources
OpenAI and Anthropic will provide up to £200 million in combined support for the AI Biosecurity Lab. Their contributions will consist of computing resources, access to AI models and technical assistance rather than an equivalent amount of direct cash funding.
OpenAI will provide £100 million in computing and model credits, along with trusted access to relevant advanced models through its Rosalind Biodefense program.
Anthropic will contribute up to £100 million in model credits, trusted model access and dedicated technical support.
Google DeepMind will collaborate with the lab’s researchers and biosecurity specialists and will look to provide trusted access to its Gemini and specialized scientific models. Basecamp Research, a UK AI life sciences company, will contribute AI biology models, technical expertise and research capabilities to address priority biosecurity challenges.
The initiative will operate as an independent nonprofit organization, with the government also seeking public and philanthropic funding to support its development over time.
The partnerships are intended to combine frontier AI capabilities with specialist biological expertise, allowing researchers and public-sector institutions to develop tools that can be applied to real-world biosecurity challenges.
UK Expands AI Security Spending Beyond Biosecurity
The £100 million laboratory forms part of a £165 million National AI Biosecurity Initiative, which also includes £65 million to strengthen biosurveillance and develop medical countermeasures against priority pathogens.
The wider government package allocates additional funding to AI safety research, cybersecurity, domestic technology development and efforts to understand AI’s economic effects.
Key investments include:
- £120 million for the AI Security Institute: Additional funding for testing advanced AI systems, researching their capabilities and risks, and developing technical standards to help mitigate potential harms.
- £60 million for the National Cyber Shield: Funding for an initiative that will use agentic AI to strengthen cyber defenses, including support for British AI and cybersecurity innovators.
- £70 million for the National Exposure and Real-Time Vulnerability Centre: A new center intended to deploy AI tools to identify cyber vulnerabilities across critical infrastructure and the wider economy.
- £60 million for the Sovereign AI Fund: Additional investment capacity to support UK AI companies, including those working in robotics, autonomous systems and advanced manufacturing.
- £60 million for research and development procurement: Funding for innovative solutions in health care, AI security, assurance and safe adoption.
- £18 million for an Advanced Chip Design Academy: Investment in domestic semiconductor design skills and Britain’s AI hardware capabilities.
The government has also allocated £23 million over three years to research the economic impact of AI and announced further measures to support regional AI development, public services and the domestic technology sector.
The package reflects an effort to strengthen Britain’s ability to develop and secure critical technologies domestically while addressing risks associated with increasingly capable AI systems.
Government Links AI Development to National Security
AI Minister Kanishka Narayan described the biosecurity lab as a central part of Britain’s effort to strengthen its scientific capabilities and prepare for emerging threats.
“Our new AI Biosecurity Lab will be a major new global institution, bringing together world-leading scientific expertise to protect people from emerging biological threats and ensure Britain leads the world in AI safety and security,” Narayan said.
He added that the government intended to strengthen domestic technological capabilities while preparing for risks posed by advances in AI.
“We cannot afford to rely entirely on technology built overseas. By backing British science, advanced chips and our own AI companies, we can strengthen our national security, rebuild Britain’s industrial strength and create good, skilled jobs across the country.”
Chancellor John Healey said the government’s approach would seek to balance the economic opportunities offered by AI with concerns about its effects on workers and national interests.
“AI will transform daily life: every firm, community, hospital, school, and every aspect of our economy can benefit.”
“I understand and share the concerns of working people, so I am setting out a distinctively British approach to AI – one that doesn’t leave workers behind and defends our national interest, while ensuring the benefits of AI-enabled growth are felt right across the country.”
Security Minister Dan Jarvis said the new investment would help Britain use AI to strengthen national security while preparing for potential threats.
“Today’s investment will help the UK seize the opportunities AI presents to strengthen our national security, while staying one step ahead of those who seek to use AI to do us harm.”
Building Preparedness for Emerging Biological Risks
The initiative comes as governments and scientific institutions increasingly examine how advanced AI systems could affect biological research, public health preparedness and security.
AI tools could help scientists analyze biological data, identify emerging disease patterns and accelerate the development of medical countermeasures. However, increasingly capable systems may also create new risks if they make certain harmful biological activities easier to pursue.
The UK government said the lab would work with the UK Health Security Agency, the Animal and Plant Health Agency and the Defence Science and Technology Laboratory as part of a broader National AI Biosecurity Initiative.
The Medicines and Healthcare products Regulatory Agency will also work with the lab to prepare for health emergencies and inform the regulation of AI-designed medicines.
Aurelia Nguyen, deputy CEO of the Coalition for Epidemic Preparedness Innovations, said advances in AI were creating both new risks and opportunities for pandemic preparedness.
“Rapid advances in AI are creating new risks related to the design and modification of pathogens, increasing the potential for both accidental and deliberate harm. But, used safely and securely, the same technology can help us detect threats earlier and design lifesaving vaccines faster, fundamentally changing what is possible in pandemic preparedness.”
She added that the initiative complemented CEPI’s efforts to strengthen preparedness for future biological threats.
The government has not yet detailed how the lab will measure its performance, how its research will be prioritized or when its initial capabilities will become operational.
Its effectiveness will depend on translating AI research into reliable tools that can be used by public-health agencies, scientists and other institutions responsible for biological security.
For the UK, the initiative represents an investment in both scientific preparedness and national security, with the government seeking to use advanced AI to improve its ability to anticipate biological risks while accelerating the development of responses to future health emergencies.